PPCB · Propanc Biopharma, Inc. · Exempt Offerings
$0.85
-0.07 (-7.71%)
At close · Sep 14
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“It is management's opinion that these conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of at least twelve months from the issue date of this Quarterly Report.”View the 10-Q filed May 14, 2026
Market Cap
$2.10M
Shares
2.28M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2023-11-03 | New | Pharmaceuticals | $40,000 | $40,000 | 06b |
| 2023-10-26 | New | Pharmaceuticals | $61,000 | $61,000 | 06b |
| 2023-08-31 | New | Pharmaceuticals | $55,000 | $55,000 | 06b |
| 2023-08-31 | New | Pharmaceuticals | $72,500 | $72,500 | 06b |
| 2023-08-30 | New | Pharmaceuticals | $120,000 | $120,000 | 06b |
| 2023-08-16 | New | Pharmaceuticals | $65,000 | $65,000 | 06b |
| 2023-08-15 | New | Pharmaceuticals | $45,000 | $45,000 | 06c |
| 2020-04-17 | New | Pharmaceuticals | $450,000 | $450,000 | 06c |
Showing 1–8 of 8 filings